BAYER AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.22 EUR | -0.90% |
|
-4.27% | -22.02% |
| 10:31am | Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains | RE |
| Apr. 15 | Eurozone Industrial Production Recovery Boosts German Stocks Amid Growing Tensions in Middle East | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-04-26
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
26.46
EUR
Average target price
37.62
EUR
Spread / Average Target
+42.17%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.02% | 27.64B | |
| +28.79% | 676B | |
| +23.74% | 559B | |
| -5.84% | 356B | |
| +15.75% | 320B | |
| +4.32% | 286B | |
| +3.04% | 213B | |
| -0.06% | 207B | |
| -9.16% | 199B | |
| -7.82% | 142B |
- Stock Market
- Equities
- BAYN Stock
- News Bayer AG
- Bayer Starts Partnership With M2i To Distribute Pheromone-based Crop Protection Products
